Fibrinogen human Completed Phase 2 Trials for Cardiovascular Heart Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01681030The Fibrin Pad Cardiovascular Study